Selected research
Industry Growth & Trends
Global Mammalian Cell Culture Service Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Mammalian Cell Culture Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Mammalian Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Mammalian Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Mammalian Cell Culture Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Mammalian Cell Culture Service market include ARVYS Proteins, Inc., Xell AG, BioXpedia, Biocompare, Sphere Fluidics, Huakan Bio, ABS Inc, Coriell Institute and BiBo Biopharma Engineering Co., LTD., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Mammalian Cell Culture Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Mammalian Cell Culture Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mammalian Cell Culture Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mammalian Cell Culture Service.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Mammalian Cell Culture Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Mammalian Cell Culture Service Market by Company
ARVYS Proteins, Inc.
Xell AG
BioXpedia
Biocompare
Sphere Fluidics
Huakan Bio
ABS Inc
Coriell Institute
BiBo Biopharma Engineering Co., LTD.
Aurelia Bioscience
Rockland
Penn Genetics
Ningbo Mingzhou Biotechnology Co., Ltd.
Lonza
FUJIFILM Diosynth Biotechnologies
Shanghai Sunway Biotech
Lerner Research Institute
Cell Biologics
Cell Culture Company
Novartis
Nordmark Pharma GmbH
Mammalian Cell Culture Service Segment by Type
Primary Cells
Transformed Cells
Self-renewing Cells
Mammalian Cell Culture Service Segment by Application
Production of Vaccines
Production of Monoclonal Antibodies
Production of Therapeutic Proteins
Others
Mammalian Cell Culture Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mammalian Cell Culture Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Mammalian Cell Culture Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mammalian Cell Culture Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Mammalian Cell Culture Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Primary Cells
- Transformed Cells
- Self-renewing Cells
Applications
- Production of Vaccines
- Production of Monoclonal Antibodies
- Production of Therapeutic Proteins
- Others
Companies covered
- ARVYS Proteins, Inc.
- Xell AG
- BioXpedia
- Biocompare
- Sphere Fluidics
- Huakan Bio
- ABS Inc
- Coriell Institute
- BiBo Biopharma Engineering Co., LTD.
- Aurelia Bioscience
- Rockland
- Penn Genetics
- Ningbo Mingzhou Biotechnology Co., Ltd.
- Lonza
- FUJIFILM Diosynth Biotechnologies
- Shanghai Sunway Biotech
- Lerner Research Institute
- Cell Biologics
- Cell Culture Company
- Novartis
- Nordmark Pharma GmbH
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Mammalian Cell Culture Service Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Mammalian Cell Culture Service Market Size by Region (2021-2032)
- 1.4.1 Global Mammalian Cell Culture Service Market Size by Region (2021-2026)
- 1.4.2 Global Mammalian Cell Culture Service Market Size by Region (2027-2032)
- 1.5 Key Regions Mammalian Cell Culture Service Market Size (2021-2032)
- 1.5.1 North America Mammalian Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Mammalian Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Mammalian Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.4 South America Mammalian Cell Culture Service Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Mammalian Cell Culture Service Market Size Growth Rate (2021-2032)
2 Mammalian Cell Culture Service Market by Type
- 2.1 Type Introduction
- 2.1.1 Primary Cells
- 2.1.2 Transformed Cells
- 2.1.3 Self-renewing Cells
- 2.2 Global Mammalian Cell Culture Service Market Size by Type
- 2.2.1 Global Mammalian Cell Culture Service Market Size Overview by Type (2021-2032)
- 2.2.2 Global Mammalian Cell Culture Service Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Mammalian Cell Culture Service Market Size Forecasted by Type (2027-2032)
- 2.3 Global Mammalian Cell Culture Service Market Size by Regions
- 2.3.1 North America Mammalian Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Mammalian Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Mammalian Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Mammalian Cell Culture Service Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Mammalian Cell Culture Service Market Size Breakdown by Type (2021-2026)
3 Mammalian Cell Culture Service Market by Application
- 3.1 Type Introduction
- 3.1.1 Production of Vaccines
- 3.1.2 Production of Monoclonal Antibodies
- 3.1.3 Production of Therapeutic Proteins
- 3.1.4 Others
- 3.2 Global Mammalian Cell Culture Service Market Size by Application
- 3.2.1 Global Mammalian Cell Culture Service Market Size Overview by Application (2021-2032)
- 3.2.2 Global Mammalian Cell Culture Service Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Mammalian Cell Culture Service Market Size Forecasted by Application (2027-2032)
- 3.3 Global Mammalian Cell Culture Service Market Size by Regions
- 3.3.1 North America Mammalian Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Mammalian Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Mammalian Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Mammalian Cell Culture Service Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Mammalian Cell Culture Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Mammalian Cell Culture Service Industry Trends
- 4.2 Mammalian Cell Culture Service Industry Drivers
- 4.3 Mammalian Cell Culture Service Industry Opportunities and Challenges
- 4.4 Mammalian Cell Culture Service Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Mammalian Cell Culture Service Revenue (2021-2026)
- 5.2 Global Mammalian Cell Culture Service Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Mammalian Cell Culture Service Key Company Headquarters & Area Served
- 5.4 Global Mammalian Cell Culture Service Company, Product Type & Application
- 5.5 Global Mammalian Cell Culture Service Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Mammalian Cell Culture Service Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Mammalian Cell Culture Service Players Market Share by Revenue in 2025
- 5.6.3 2025 Mammalian Cell Culture Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ARVYS Proteins, Inc.
- 6.1.1 ARVYS Proteins, Inc. Company Information
- 6.1.2 ARVYS Proteins, Inc. Business Overview
- 6.1.3 ARVYS Proteins, Inc. Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ARVYS Proteins, Inc. Mammalian Cell Culture Service Product Portfolio
- 6.1.5 ARVYS Proteins, Inc. Recent Developments
- 6.2 Xell AG
- 6.2.1 Xell AG Company Information
- 6.2.2 Xell AG Business Overview
- 6.2.3 Xell AG Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Xell AG Mammalian Cell Culture Service Product Portfolio
- 6.2.5 Xell AG Recent Developments
- 6.3 BioXpedia
- 6.3.1 BioXpedia Company Information
- 6.3.2 BioXpedia Business Overview
- 6.3.3 BioXpedia Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 BioXpedia Mammalian Cell Culture Service Product Portfolio
- 6.3.5 BioXpedia Recent Developments
- 6.4 Biocompare
- 6.4.1 Biocompare Company Information
- 6.4.2 Biocompare Business Overview
- 6.4.3 Biocompare Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Biocompare Mammalian Cell Culture Service Product Portfolio
- 6.4.5 Biocompare Recent Developments
- 6.5 Sphere Fluidics
- 6.5.1 Sphere Fluidics Company Information
- 6.5.2 Sphere Fluidics Business Overview
- 6.5.3 Sphere Fluidics Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Sphere Fluidics Mammalian Cell Culture Service Product Portfolio
- 6.5.5 Sphere Fluidics Recent Developments
- 6.6 Huakan Bio
- 6.6.1 Huakan Bio Company Information
- 6.6.2 Huakan Bio Business Overview
- 6.6.3 Huakan Bio Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Huakan Bio Mammalian Cell Culture Service Product Portfolio
- 6.6.5 Huakan Bio Recent Developments
- 6.7 ABS Inc
- 6.7.1 ABS Inc Company Information
- 6.7.2 ABS Inc Business Overview
- 6.7.3 ABS Inc Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 ABS Inc Mammalian Cell Culture Service Product Portfolio
- 6.7.5 ABS Inc Recent Developments
- 6.8 Coriell Institute
- 6.8.1 Coriell Institute Company Information
- 6.8.2 Coriell Institute Business Overview
- 6.8.3 Coriell Institute Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Coriell Institute Mammalian Cell Culture Service Product Portfolio
- 6.8.5 Coriell Institute Recent Developments
- 6.9 BiBo Biopharma Engineering Co., LTD.
- 6.9.1 BiBo Biopharma Engineering Co., LTD. Company Information
- 6.9.2 BiBo Biopharma Engineering Co., LTD. Business Overview
- 6.9.3 BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 BiBo Biopharma Engineering Co., LTD. Mammalian Cell Culture Service Product Portfolio
- 6.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments
- 6.10 Aurelia Bioscience
- 6.10.1 Aurelia Bioscience Company Information
- 6.10.2 Aurelia Bioscience Business Overview
- 6.10.3 Aurelia Bioscience Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Aurelia Bioscience Mammalian Cell Culture Service Product Portfolio
- 6.10.5 Aurelia Bioscience Recent Developments
- 6.11 Rockland
- 6.11.1 Rockland Company Information
- 6.11.2 Rockland Business Overview
- 6.11.3 Rockland Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Rockland Mammalian Cell Culture Service Product Portfolio
- 6.11.5 Rockland Recent Developments
- 6.12 Penn Genetics
- 6.12.1 Penn Genetics Company Information
- 6.12.2 Penn Genetics Business Overview
- 6.12.3 Penn Genetics Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Penn Genetics Mammalian Cell Culture Service Product Portfolio
- 6.12.5 Penn Genetics Recent Developments
- 6.13 Ningbo Mingzhou Biotechnology Co., Ltd.
- 6.13.1 Ningbo Mingzhou Biotechnology Co., Ltd. Company Information
- 6.13.2 Ningbo Mingzhou Biotechnology Co., Ltd. Business Overview
- 6.13.3 Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Ningbo Mingzhou Biotechnology Co., Ltd. Mammalian Cell Culture Service Product Portfolio
- 6.13.5 Ningbo Mingzhou Biotechnology Co., Ltd. Recent Developments
- 6.14 Lonza
- 6.14.1 Lonza Company Information
- 6.14.2 Lonza Business Overview
- 6.14.3 Lonza Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Lonza Mammalian Cell Culture Service Product Portfolio
- 6.14.5 Lonza Recent Developments
- 6.15 FUJIFILM Diosynth Biotechnologies
- 6.15.1 FUJIFILM Diosynth Biotechnologies Company Information
- 6.15.2 FUJIFILM Diosynth Biotechnologies Business Overview
- 6.15.3 FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 FUJIFILM Diosynth Biotechnologies Mammalian Cell Culture Service Product Portfolio
- 6.15.5 FUJIFILM Diosynth Biotechnologies Recent Developments
- 6.16 Shanghai Sunway Biotech
- 6.16.1 Shanghai Sunway Biotech Company Information
- 6.16.2 Shanghai Sunway Biotech Business Overview
- 6.16.3 Shanghai Sunway Biotech Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Shanghai Sunway Biotech Mammalian Cell Culture Service Product Portfolio
- 6.16.5 Shanghai Sunway Biotech Recent Developments
- 6.17 Lerner Research Institute
- 6.17.1 Lerner Research Institute Company Information
- 6.17.2 Lerner Research Institute Business Overview
- 6.17.3 Lerner Research Institute Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Lerner Research Institute Mammalian Cell Culture Service Product Portfolio
- 6.17.5 Lerner Research Institute Recent Developments
- 6.18 Cell Biologics
- 6.18.1 Cell Biologics Company Information
- 6.18.2 Cell Biologics Business Overview
- 6.18.3 Cell Biologics Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Cell Biologics Mammalian Cell Culture Service Product Portfolio
- 6.18.5 Cell Biologics Recent Developments
- 6.19 Cell Culture Company
- 6.19.1 Cell Culture Company Company Information
- 6.19.2 Cell Culture Company Business Overview
- 6.19.3 Cell Culture Company Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 Cell Culture Company Mammalian Cell Culture Service Product Portfolio
- 6.19.5 Cell Culture Company Recent Developments
- 6.20 Novartis
- 6.20.1 Novartis Company Information
- 6.20.2 Novartis Business Overview
- 6.20.3 Novartis Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.20.4 Novartis Mammalian Cell Culture Service Product Portfolio
- 6.20.5 Novartis Recent Developments
- 6.21 Nordmark Pharma GmbH
- 6.21.1 Nordmark Pharma GmbH Company Information
- 6.21.2 Nordmark Pharma GmbH Business Overview
- 6.21.3 Nordmark Pharma GmbH Mammalian Cell Culture Service Revenue, Global Share and Gross Margin (2021-2026)
- 6.21.4 Nordmark Pharma GmbH Mammalian Cell Culture Service Product Portfolio
- 6.21.5 Nordmark Pharma GmbH Recent Developments
7 North America
- 7.1 North America Mammalian Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 7.3 North America Mammalian Cell Culture Service Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Mammalian Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 8.3 Europe Mammalian Cell Culture Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Mammalian Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Mammalian Cell Culture Service Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Mammalian Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 10.3 South America Mammalian Cell Culture Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Mammalian Cell Culture Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Mammalian Cell Culture Service Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Mammalian Cell Culture Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst